Scalzo Richard William
Chief Financial Officer
Scalzo Richard William has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Sep 18, 2026.
On the most recent filing, Scalzo Richard William is listed as Chief Financial Officer at CRESCENT BIOPHARMA, INC. Inside the rolling window, Scalzo Richard William reported no open-market purchases and 2 open-market sales totaling $30K in CBIO. The largest disclosed transaction in the window is a sale of 1,112 CBIO shares on Jun 22, 2026, worth $20K.
Companies traded
Other insiders at CBIO
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$30K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Scalzo Richard William made?
Scalzo Richard William has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Scalzo Richard William trade?
Scalzo Richard William has filed SEC Form 4 disclosures for 1 company, including CBIO.
When was Scalzo Richard William's most recent SEC Form 4 filing?
Scalzo Richard William's most recent SEC Form 4 filing on Tracefour is dated Sep 18, 2026.
What is Scalzo Richard William's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Scalzo Richard William is listed as Chief Financial Officer.
What is Scalzo Richard William's total buy and sell value in the current window?
Inside the rolling retention window, Scalzo Richard William bought $0 and sold $30K based on SEC Form 4 filings.
What was Scalzo Richard William's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,112 CBIO shares on 2026-06-22, worth $20K, per SEC Form 4 filings.